There was no significant difference in the proportion of Tregs defined by “FOXP3-positive alone” in PB between RA patients and control subjects (REM 0.72, [-0.72 to 2.16]) (I2 = 86.5%, P = 0.0006). This evidence concerns the gene FOXP3 and rheumatoid arthritis.